The Acute Leukemia Mini Panel, also known as AMLETO, is a comprehensive diagnostic test specifically designed to identify key genetic mutations and translocations associated with acute leukemia. This panel focuses on several critical markers, including INV16, PML-RARA, BCR-ABL, TEL-AML1, MLL, and E2A, which are pivotal in diagnosing, prognosticating, and guiding the treatment strategies for patients with acute leukemia.
Performed at DNA Labs UAE, a reputable facility known for its advanced genetic testing capabilities, the AMLETO panel employs sophisticated molecular techniques to detect the presence of these genetic abnormalities. By targeting these specific markers, the test provides valuable insights into the subtype of leukemia, helping healthcare professionals tailor treatment plans to the individual patient's genetic profile.
The cost of the Acute Leukemia Mini Panel AMLETO at DNA Labs UAE is 2340 AED. This investment in precise genetic testing can be crucial for achieving better outcomes in the management of acute leukemia, enabling more personalized and effective treatment approaches.
The H9N7 and Influenza A Viral Load Quantitative Test is a specialized diagnostic procedure designed to accurately measure and quantify the viral load of the H9N7 strain, along with other Influenza A viruses, in a patient's body. This test is crucial for the early detection and management of infections caused by these viruses, which are known for their potential to cause severe respiratory illnesses and outbreaks.
Performed at DNA Labs UAE, a leading facility in the field of molecular diagnostics and genetic testing, this test utilizes advanced molecular techniques to detect and quantify the RNA of the viruses. This allows healthcare providers to not only confirm the presence of the virus but also to monitor the progression of the infection and the effectiveness of antiviral treatment over time.
The cost of the H9N7 and Influenza A Viral Load Quantitative Test at DNA Labs UAE is 2310 AED. This price reflects the sophisticated technology and expertise required to accurately perform the test and interpret the results. Patients undergoing this test can expect a high level of accuracy and reliability, aiding in the timely and effective management of their condition.
The "Her-2 Neu DNA Detection and Quantification RNA Detection Qualitative Test" is a sophisticated diagnostic procedure offered by DNA Labs UAE, designed to accurately identify and measure the presence of the HER2/neu gene in DNA and its expression levels in RNA. The HER2/neu gene is known for its role in the development of certain types of cancer, most notably breast cancer, where its overexpression can influence the aggressiveness of the disease and its response to specific treatments.
This test employs advanced molecular biology techniques to qualitatively assess the HER2/neu gene status, providing crucial information that aids in the diagnosis, prognosis, and tailoring of treatment plans for patients. By detecting and quantifying the HER2/neu gene in both DNA and RNA, the test offers a comprehensive view of the gene's impact on cancer progression.
The cost of the test is 2310 AED, reflecting the intricate technology and expertise required to perform this detailed analysis. Conducted in the state-of-the-art facilities of DNA Labs UAE, this test is a valuable tool for healthcare providers, enabling them to make informed decisions and offer personalized therapy options to patients with HER2/neu-positive cancers.
The "Marburg, Lassa, and Ebola Multiplex Detection and Differentiation RNA Detection Qualitative Test" is a highly specialized diagnostic tool available at DNA Labs UAE. This innovative test is designed to accurately identify and differentiate between the RNA of Marburg virus, Lassa fever virus, and Ebola virus, three of the most deadly viral hemorrhagic fevers known to affect humans. Utilizing advanced multiplex PCR technology, this qualitative assay allows for the simultaneous detection of these viruses in a single test, providing critical information for the timely and effective management of suspected cases.
Given the severe morbidity and mortality associated with these diseases, rapid and precise diagnosis is paramount for initiating appropriate infection control measures, treatment protocols, and, when available, the use of antiviral drugs. The test is priced at 2310 AED, reflecting the sophisticated technology and expertise required to perform it. By offering this test, DNA Labs UAE plays a crucial role in enhancing public health preparedness and response capabilities against these high-consequence infectious diseases.
The "MERS Middle East Respiratory Syndrome UpEORF1a and ORF1b Multiplex Detection and Differentiation RNA Detection Qualitative Test" is a sophisticated diagnostic tool used to identify and differentiate the RNA of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in patients. This test specifically targets the upstream EORF1a and ORF1b regions of the virus's genome, employing a multiplex approach that allows for the simultaneous detection of both genetic markers. This method ensures a high level of accuracy and specificity in diagnosing MERS-CoV, which is crucial for timely patient management and containment of the virus spread.
The test is conducted at DNA Labs UAE, a leading facility in the field of molecular diagnostics and genetic testing. DNA Labs UAE is equipped with state-of-the-art technology and staffed by experts in virology and molecular biology, ensuring reliable and accurate test results.
The cost of the test is set at 2310 AED, reflecting the complexity of the technology used and the expertise required to perform the analysis. Despite the cost, the test provides critical information for the effective treatment and control of MERS, a potentially deadly respiratory illness that has been a significant health concern in the Middle East and beyond.
The PML/RARA Quantitative Test is a specialized diagnostic procedure aimed at detecting the PML/RARA fusion gene, which is primarily associated with Acute Promyelocytic Leukemia (APL), a subtype of acute myeloid leukemia. This test is crucial for the diagnosis, prognosis, and monitoring of treatment response in patients with APL. Utilizing advanced molecular techniques, the test quantifies the presence of the PML/RARA gene rearrangement, providing essential information for tailored treatment strategies.
Conducted at DNA Labs UAE, a reputable facility known for its state-of-the-art technology and expert staff, the test ensures high accuracy and reliability. The cost of the PML/RARA Quantitative Test at DNA Labs UAE is set at 2310 AED. This investment is pivotal for patients requiring precise diagnosis and monitoring, offering critical insights that guide effective treatment plans and contribute to improved patient outcomes in the battle against Acute Promyelocytic Leukemia.
The "Parainfluenza 1234 Multiplex Detection and Differentiation Quantitative Test" is an advanced diagnostic procedure offered by DNA Labs UAE, designed to accurately identify and differentiate between the four types of human parainfluenza viruses (HPIVs). These viruses are significant pathogens that cause a variety of respiratory illnesses, from mild colds to severe pneumonia and bronchitis, particularly in children, the elderly, and immunocompromised individuals.
Utilizing cutting-edge multiplex PCR technology, this test simultaneously amplifies and detects specific genetic markers for each of the HPIV types - 1, 2, 3, and 4. This allows for a comprehensive analysis in a single assay, providing not only a confirmation of the presence of the virus but also identifying the specific type, which is crucial for appropriate clinical management and treatment strategies.
The cost of the test is set at 2310 AED, reflecting the sophisticated technology and the detailed, valuable insights it offers into the patient's viral infection status. Conducted in the state-of-the-art facilities of DNA Labs UAE, this test represents a significant advancement in the field of infectious disease diagnostics, offering rapid, accurate, and differentiated results that can significantly impact patient care and infection control measures.
The RARAPML Quantitative Test is a specialized diagnostic assessment offered by DNA Labs UAE, designed to quantitatively measure the RARAPML gene's expression levels. This test is particularly significant in the field of medical genetics and oncology, providing crucial information that assists in the diagnosis, prognosis, and treatment planning for certain types of cancers, including acute myeloid leukemia (AML). By accurately quantifying the RARAPML gene expression, healthcare professionals can make more informed decisions regarding patient care. The test is conducted using advanced molecular techniques, ensuring precise and reliable results. The cost for undergoing the RARAPML Quantitative Test at DNA Labs UAE is 2310 AED, reflecting the sophisticated nature of the technology and expertise required to perform the analysis.
The RSV A and RSV B Viral Load Quantitative Test is a diagnostic assessment offered by DNA Labs UAE, designed to accurately measure the amount of Respiratory Syncytial Virus (RSV) types A and B in a patient's blood. RSV is a common respiratory virus that causes infections in the lungs and respiratory tract, and it can be particularly severe in infants, young children, and the elderly. The quantitative nature of this test allows healthcare providers to determine the viral load, which can be crucial for assessing the severity of the infection, monitoring the course of the disease, and guiding treatment decisions.
The test involves collecting a sample from the patient, which is then analyzed using sophisticated laboratory techniques to quantify the amount of RSV genetic material present. This level of detail helps in understanding the progression of the infection and can be vital in high-risk cases where tailored treatment plans are necessary.
At DNA Labs UAE, the cost of the RSV A and RSV B Viral Load Quantitative Test is set at 2310 AED. This price reflects the advanced technology and expertise required to perform this specialized diagnostic test. By providing this service, DNA Labs UAE plays a crucial role in the timely and accurate diagnosis of RSV infections, contributing to better patient outcomes through precise and personalized care.
The Zika Virus Viral Load Quantitative Test is a sophisticated diagnostic tool utilized to measure the amount of Zika virus RNA present in a patient's blood. This test is crucial for identifying and managing Zika virus infections, particularly in pregnant women, due to the virus's potential to cause severe birth defects such as microcephaly and other congenital anomalies. By quantifying the viral load, healthcare providers can assess the severity of the infection and monitor the effectiveness of treatment strategies.
Performed at DNA Labs UAE, a leading laboratory known for its advanced diagnostic services, the test employs cutting-edge molecular techniques to ensure accurate and reliable results. The cost of the Zika Virus Viral Load Quantitative Test at DNA Labs UAE is 2310 AED. This investment is vital for those at risk or showing symptoms of Zika virus infection, as it provides essential information for timely and appropriate medical intervention.
